Transgene Appoints Jean-Yves Bonnefoy as New Chief Scientific Officer STRASBOURG, France, Feb. 15 /PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Euronext: FR0005175080) announced today the appointment of Dr. Jean-Yves Bonnefoy as its new Chief Scientific Officer. He replaces Serge Braun who has decided to pursue other opportunities outside of the Company. Prior to joining Transgene, Jean-Yves Bonnefoy, 45, was Head of the Canceropole Lyon Rhones-Alpes. From 1997 to 2002, he was Director of the Immunology Center of the Pierre Fabre Group in Saint-Julien en Genevois, France. He previously was responsible for the Immunology Department of the Biomedical Research Institute of the Glaxo-Wellcome Group in Geneva, Switzerland. Jean-Yves Bonnefoy holds a PhD in immunology from the Lyons Claude Bernard University and has completed the Senior Management Program of the London Business School. "We thank Serge Braun for his contribution to the development of Transgene," stated Philippe Archinard, Chief Executive Officer of Transgene. "We are delighted to integrate Jean-Yves' immunology experience and background in the infectiology and oncology fields. His arrival will allow us to reinforce Transgene as a company dedicated to therapeutic vaccination." About Transgene Transgene, based in Strasbourg, France, is a biopharmaceutical company dedicated to the discovery and development of therapeutic vaccines, immunotherapy products, and delivery technologies for the treatment of diseases for which there is no cure or adequate treatment at present, with a focus on the treatment of cancer. Transgene has five products in clinical development, two of which are in Phase II clinical trials, two in Phase I/II and one that has completed Phase I clinical trial. Transgene's proprietary vector technology platform consists of adenovirus and poxvirus vector families. DATASOURCE: Transgene CONTACT: Philippe Poncet, C.F.O. and Investors Relations, Transgene, +33-3-88-27-91-01; Michael Long, Cohn & Wolfe, +1-415-365-8523, for Transgene; Tiphaine Hecketsweiler, Image 7, +33-1-53-70-74-70, for Transgene Web site: http://www.transgene.fr/

Copyright